COIMBRA

The Cohort for patient-reported Outcomes, Imaging and trial inclusion in Metastatic BRAin disease - COIMBRA

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON52435

Enrollment

2000

Registered

2018-09-04

Start date

2019-04-26

Completion date

Unknown

Last updated

2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain metastases metastatic brain disease

Interventions

&nbsp

New MRI techniques are being evaluated.&nbsp

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria:  - Age >= 18 years; - Either radiographic and/or histologic proof of metastatic brain disease, or  eligible for prophylactic cranial irradiation; - Referred to the Department of Radiotherapy for cranial irradiation. 

Exclusion criteria

Exclusion criteria:  - Mental disorder or cognitive dysfunction that hinder the patient*s ability to  understand the informed consent procedure and/or study details; - Patients with severe psychiatric disorders; - Inability to understand the Dutch language. 

Design outcomes

Primary

Measure	Time frame
Clinical parameters (co-morbidity, oncological history, symptoms, imaging, technical and treatment data), clinical endpoints (toxicity, reintervention and survival) and patient reported outcomes.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Contacts

Public ContactM.E.P. Philippens

Universitair Medisch Centrum Utrecht

coimbra@umcutrecht.nl+31 (0)88 75 53188

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)